Table 1 Baseline characteristics and outcome of matched children
From: Impact of tight glucose control on circulating 3-hydroxybutyrate in critically ill patients
Baseline characteristics | Liberal GC (N = 50) | Tight GC (N = 50) | P value |
|---|---|---|---|
Age (years)—median (IQR) | 0.9 (0.2–2.9) | 0.6 (0.2–3.1) | 0.79 |
Age groupa | 0.39 | ||
Neonate—no. (%) | 4 (8) | 8 (16) | |
Infant—no. (%) | 23 (46) | 19 (38) | |
Child—no. (%) | 23 (46) | 23 (46) | |
Weight (kg)—median (IQR) | 7.7 (4.2–11.5) | 6.6 (3.8–13.9) | 0.75 |
Sex (male)—no. (%) | 25 (50) | 27 (54) | 0.84 |
Diagnostic category | 1.00 | ||
Surgical | |||
Transplantation—no. (%) | 1 (2) | 1 (2) | |
Cardiac surgery—no. (%) | 41 (82) | 40 (80) | |
Other surgery—no. (%) | 4 (8) | 5 (10) | |
Medical—no. (%) | 4 (8) | 4 (8) | |
PELOD first 24 h in ICU—median (IQR) | 12 (11–12) | 12 (11–12) | 0.53 |
ECMO or other assist device—no. (%) | 1 (2) | 1 (2) | 1.00 |
Outcome | |||
|---|---|---|---|
ICU mortality—no. (%) | 4 (8) | 1 (2) | 0.36 |
Length of ICU stay (days)—median (IQR) | 5 (3–9) | 6 (3–10) | 0.80 |
Patients with secondary infection—no. (%) | 28 (56) | 23 (46) | 0.42 |